François Hollande has appointed Professor Agnès Buzyn to head the High Authority for Health. This body draws up recommendations for medical practice.
Since this Monday, middle School of the High Authority of Health (HAS) has a new person in charge. This is Prof. Agnès Buzyn who, by presidential decree, has just been appointed to lead this body responsible for issuing recommendations on medical practice. This hematologist therefore takes up her duties as of March 7, 2016, replacing Professor Jean-Luc Harousseau, who has resigned.
In a press release, the instance recalls its course. Agnès Buzyn, aged 53, has held the presidency since May 2011 of the National Cancer Institute (INCa). During her tenure, she notably implemented the 3rd Cancer Plan 2014-2019 focused on the fight against losses of luck in the face of illness.
It is the “right to be forgotten”, from which certain patients can now benefit from banking and insurance establishments.
More recently, Agnès Buzyn also denounced the relaxation of the Evin law within the framework of the Health law of Marisol Touraine. After reminding daily The world that alcohol kills 49,000 people each year in France (including 15,000 by cancer), she declared herself, at the end of 2015, “surprised” and “very worried” by this desire to change the legislation. “The Evin law already authorizes advertising on many media, it would be unreasonable to open it more,” she said.
150 scientific publications
On the medical side, she carried out most of of his journey of hematologist clinician (doctor specializing in blood diseases) at Necker hospital (Paris) where she was responsible of Unity of intensive adult hematology care and of graft of bone marrow of 1992 to 2011.
Appointed Professor at the University of Paris V in 2004, she taught hematology and tumor immunology and of transplantation in several university modules.
His numerous works in the fields of the graft of bone marrow, of acute lymphoblastic leukemia (ALL) and of myeloid leukemiaof chronic (CML) have thus given rise to more of 150 original publications in international scientific journals.
The president always consults
In addition, beyond INCa, Agnès Buzyn has worked of many functions within others Learned societies and of the administration’s advice. Both a member of the medical and scientific council of the agency of biomedicine (ABM), member of the scientific council of the French Blood Establishment (EFS), or even, President of the Scientific Council of the French company of graft of marrow and of cell therapy (SFGM-TC). All without forgetting the patients.
Under his chairmanship, INCa devised a new system to improve equity and speed of access to innovative drugs for patients with cancer and in a situation of treatment failure. This program called “AcSé” (Secure access to innovative therapies) has experienced a first positive assessment.
And in order to keep in touch with these patients, Agnès Buzyn has chosen to keep an activity of hematology consultation at the Saint-Antoine hospital of the AP-HP (Paris 12e). A passion for the world of health that is shared with the family because she is also the wife of Yves Lévy, the current President and CEO of Inserm (National Institute for Health and Medical Research).
.
